GlassScriptPhysician profile
Donald Earl Baker
NPI 1457513202
$1,751.82
in general payments reported to CMS, 2019-2025
21 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $740 · 2021: $246 · 2022: $43.26 · 2023: $12.81 · 2024: $145 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $622.23 | 2020 | |
| Stryker Corporation | $186.74 | 2019-2024 | Mako |
| Depuy Synthes Sales INC. | $176.61 | 2019-2021 | |
| Boston Scientific Corporation | $142.05 | 2021-2025 | General - Pain Management |
| Encore Medical, LP | $129.64 | 2019-2022 | |
| Smith+Nephew, INC. | $57.64 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Innovation Technologies INC | $56.14 | 2024 | Irrisept |
| Davol INC. | $55.43 | 2024-2025 | Channel Drain |
| Bioventus LLC | $50.52 | 2020-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Orthalign INC | $49.66 | 2021 | |
| Pacira Therapeutics, INC. | $39.13 | 2019 | |
| Abbott Laboratories | $29.88 | 2025 | Eterna |
| Axogen | $23.65 | 2019 | |
| Fidia Pharma USA INC. | $23.52 | 2020 | |
| Ferring Pharmaceuticals INC. | $19.04 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $17.46 | 2022 | |
| Radius Health, INC. | $16.42 | 2020 | |
| Wound Management Technologies, INC | $16.40 | 2019 | |
| Djo, LLC | $14.56 | 2019 | |
| Medtronic, INC. | $12.81 | 2023 | Aquamantys(Tm) |
| Nabriva Therapeutics, Plc | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.